ACE2 rupture force

27 single-molecule force spectroscopy studies (2020–2026), 2 with a public dataset.

Reported forces

ObservableValueTechniqueYearStudySource sentence
Unfolding force40 pNAFM2022A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions.This initial peak is followed by a trident-shaped, three-peak pattern at around 40 pN.
Rupture force1,500 pNAFM2022A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions.The final ClfA:Fgɣ rupture at >1,500 pN is not shown, for clarity.
Unbinding force26 pNAFM2022A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions.an initial (leftmost) peak typically at lower forces around 26 pN for the SARS-CoV-1 fusion construct and about twice as high forces for the SARS-CoV-2 fusion construct (around 57 pN; Fig. 2 A, Inset)
Unbinding force57 pNAFM2022A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions.an initial (leftmost) peak typically at lower forces around 26 pN for the SARS-CoV-1 fusion construct and about twice as high forces for the SARS-CoV-2 fusion construct (around 57 pN; Fig. 2 A, Inset)
Contour length increment53 nmAFM2022A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions.The contour length increments of the first peaks (53 and 66 nm for the short and long linkers, respectively), are, however, larger than what is expected from interface opening only
Contour length increment66 nmAFM2022A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions.The contour length increments of the first peaks (53 and 66 nm for the short and long linkers, respectively), are, however, larger than what is expected from interface opening only

Values as reported in each paper (auto-extracted from abstracts and AI-reviewed full texts); loading rates, constructs and buffers differ between studies, so compare with care.

Summary by observable

ObservableReportsRangeMedianStudies
Unbinding force226–57 pN41.5 pN001395 001395
Contour length increment253–66 nm59.5 nm001395 001395
Unfolding force140 pN40 pN001395
Rupture force11,500 pN1,500 pN001395

Values converted to common units; conditions differ between studies.

About this system

Essential counter-regulatory carboxypeptidase of the renin-angiotensin hormone system that is a critical regulator of blood volume, systemic vascular resistance, and thus cardiovascular homeostasis. Converts angiotensin I to angiotensin 1-9, a nine-amino acid peptide with anti-hypertrophic effects in cardiomyocytes, and angiotensin II to angiotensin 1-7, which then acts as a beneficial vasodilator and anti-proliferation agent, counterbalancing the actions of the vasoconstrictor angiotensin II. Also removes the C-terminal residue from three other vasoactive peptides, neurotensin, kinetensin, and des-Arg bradykinin, but is not active on bradykinin. Also cleaves other biological peptides, such as apelins (apelin-13, [Pyr1]apelin-13, apelin-17, apelin-36), casomorphins (beta-casomorphin-7, neocasomorphin) and dynorphin A with high efficiency. In addition, ACE2 C-terminus is homologous to collectrin and is responsible for the trafficking of the neutral amino acid transporter SL6A19 to the plasma membrane of gut epithelial cells via direct interaction, regulating its expression on the cell surface and its catalytic activity

From UniProt Q9BYF1 · CC BY 4.0

Angiotensin-converting enzyme 2 (ACE2) is an enzyme that can be found either attached to the membrane of cells (mACE2) in the intestines, kidney, testis, gallbladder, and heart or in a soluble form (sACE2). Both membrane bound and soluble ACE2 are integral parts of the renin–angiotensin–aldosterone system (RAAS) that exists to keep the body's blood pressure in check. mACE2 is cleaved by the enzyme ADAM17 in a process regulated by substrate presentation. ADAM17 cleavage releases the extracellular domain creating soluble ACE2 (sACE2). ACE2 enzyme activity opposes the classical arm of the RAAS by lowering blood pressure through catalyzing the hydrolysis of angiotensin II into angiotensin (1–7). Angiotensin (1-7) in turns binds to MasR receptors creating localized vasodilation and hence decreasing blood pressure. This decrease in blood pressure makes the entire process a promising drug targe

From Wikipedia, Angiotensin-converting enzyme 2 · CC BY-SA 4.0

Techniques

AFM force spectroscopy (20), Magnetic tweezers (4), Force spectroscopy (2), Optical tweezers (1)

Related

Studies